Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D M Fletcher

Showing results (261-270 of 311) with videos related to

Pageof 32
Sort By:
International Journal of Surgical Pathology|June 21, 2002
Diagnosis of gastrointestinal stromal tumors: a consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.
Human Pathology|July 3, 2002
Diagnosis of gastrointestinal stromal tumors: A consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.
Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.
Genes, Chromosomes & Cancer|February 17, 2012
Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genesYuesheng Jin, Emely Möller, Karolin H Nord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumorsAndrew J Wagner, Izabela Malinowska-Kolodziej, Jeffrey A Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITCharles D Blanke, George D Demetri, Margaret von Mehren, et al.
Archives of Pathology & Laboratory Medicine|February 4, 2010
Protocol for the examination of specimens from patients with gastrointestinal stromal tumorBrian P Rubin, Charles D Blanke, George D Demetri, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumorsStéphane Berghmans, Ryan D Murphey, Erno Wienholds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2013
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelinesGeorge D Demetri, Robert Benjamin, Charles D Blanke, et al.
The American Journal of Surgical Pathology|March 26, 2026
FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1::RELA Fusion in Pediatric Proliferative FasciitisSanhong Yu, Fleur Cordier, Esther Baranov, et al.
Pageof 32

Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
International Journal of Surgical Pathology|June 21, 2002
Diagnosis of gastrointestinal stromal tumors: a consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.
Human Pathology|July 3, 2002
Diagnosis of gastrointestinal stromal tumors: A consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.
Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.
Genes, Chromosomes & Cancer|February 17, 2012
Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genesYuesheng Jin, Emely Möller, Karolin H Nord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumorsAndrew J Wagner, Izabela Malinowska-Kolodziej, Jeffrey A Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITCharles D Blanke, George D Demetri, Margaret von Mehren, et al.
Archives of Pathology & Laboratory Medicine|February 4, 2010
Protocol for the examination of specimens from patients with gastrointestinal stromal tumorBrian P Rubin, Charles D Blanke, George D Demetri, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumorsStéphane Berghmans, Ryan D Murphey, Erno Wienholds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2013
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelinesGeorge D Demetri, Robert Benjamin, Charles D Blanke, et al.
The American Journal of Surgical Pathology|March 26, 2026
FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1::RELA Fusion in Pediatric Proliferative FasciitisSanhong Yu, Fleur Cordier, Esther Baranov, et al.
Pageof 32